Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25355 | 236 | 35.4 | 71% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IBOGAINE | Author keyword | 221 | 82% | 54% | 127 |
2 | NORIBOGAINE | Author keyword | 72 | 100% | 10% | 23 |
3 | 18 METHOXYCORONARIDINE | Author keyword | 38 | 84% | 9% | 21 |
4 | TABERNANTHE IBOGA | Author keyword | 12 | 86% | 3% | 6 |
5 | PHARMACOL NEUROSCI A136 | Address | 6 | 80% | 2% | 4 |
6 | IBOGA ALKALOID | Author keyword | 4 | 67% | 2% | 4 |
7 | 12 HYDROXYIBOGAMINE | Author keyword | 4 | 75% | 1% | 3 |
8 | IBOGAMINE | Author keyword | 3 | 60% | 1% | 3 |
9 | ALPHA 3 BETA 4 NICOTINIC RECEPTORS | Author keyword | 2 | 67% | 1% | 2 |
10 | ANTI ADDICTIVE | Author keyword | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IBOGAINE | 221 | 82% | 54% | 127 | Search IBOGAINE | Search IBOGAINE |
2 | NORIBOGAINE | 72 | 100% | 10% | 23 | Search NORIBOGAINE | Search NORIBOGAINE |
3 | 18 METHOXYCORONARIDINE | 38 | 84% | 9% | 21 | Search 18+METHOXYCORONARIDINE | Search 18+METHOXYCORONARIDINE |
4 | TABERNANTHE IBOGA | 12 | 86% | 3% | 6 | Search TABERNANTHE+IBOGA | Search TABERNANTHE+IBOGA |
5 | IBOGA ALKALOID | 4 | 67% | 2% | 4 | Search IBOGA+ALKALOID | Search IBOGA+ALKALOID |
6 | 12 HYDROXYIBOGAMINE | 4 | 75% | 1% | 3 | Search 12+HYDROXYIBOGAMINE | Search 12+HYDROXYIBOGAMINE |
7 | IBOGAMINE | 3 | 60% | 1% | 3 | Search IBOGAMINE | Search IBOGAMINE |
8 | ALPHA 3 BETA 4 NICOTINIC RECEPTORS | 2 | 67% | 1% | 2 | Search ALPHA+3+BETA+4+NICOTINIC+RECEPTORS | Search ALPHA+3+BETA+4+NICOTINIC+RECEPTORS |
9 | ANTI ADDICTIVE | 2 | 67% | 1% | 2 | Search ANTI+ADDICTIVE | Search ANTI+ADDICTIVE |
10 | CORONARIDINE | 2 | 67% | 1% | 2 | Search CORONARIDINE | Search CORONARIDINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTI ADDICTIVE DRUG | 44 | 85% | 10% | 23 |
2 | 12 HYDROXYIBOGAMINE | 30 | 100% | 5% | 12 |
3 | NORIBOGAINE | 23 | 86% | 5% | 12 |
4 | PARASAGITTAL ZONES | 21 | 61% | 10% | 23 |
5 | INDUCED LOCOMOTOR STIMULATION | 14 | 51% | 8% | 19 |
6 | ALKALOID IBOGAINE | 14 | 100% | 3% | 7 |
7 | 18 METHOXYCORONARIDINE | 12 | 59% | 6% | 13 |
8 | TABERNANTHE IBOGA | 9 | 83% | 2% | 5 |
9 | IBOGAINE | 9 | 34% | 9% | 21 |
10 | ALPHA 3 BETA 4 NICOTINIC RECEPTORS | 7 | 67% | 3% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The ibogaine medical subculture | 2008 | 30 | 85 | 62% |
Fatalities Temporally Associated with the Ingestion of Ibogaine | 2012 | 14 | 118 | 51% |
Ibogaine and noribogaine: Comparing parent compound to metabolite | 2000 | 8 | 86 | 95% |
Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment | 2003 | 59 | 93 | 35% |
Janusz Supniewski as a researcher of psychotropic drugs (on his 100th birthday) | 2000 | 0 | 1 | 100% |
Lbogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-D-aspartate receptors | 2003 | 18 | 36 | 50% |
Ibogaine related sudden death: A case report | 2013 | 2 | 18 | 39% |
Ibogaine and cocaine abuse: Pharmacological interactions at dopamine and serotonin receptors | 1997 | 16 | 62 | 53% |
The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation | 2015 | 0 | 62 | 52% |
Ibogaine interferes with motivational and somatic effects of naloxone-precipitated withdrawal from acutely administered morphine | 2002 | 7 | 16 | 56% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACOL NEUROSCI A136 | 6 | 80% | 1.7% | 4 |
2 | ANALYT TOXICOL CHEM | 2 | 24% | 2.5% | 6 |
3 | ROW SCI | 1 | 50% | 0.8% | 2 |
4 | NEUROL MOL CELLULAR PHARMACOL | 1 | 33% | 0.8% | 2 |
5 | MED CHEM CHEM DEV | 1 | 50% | 0.4% | 1 |
6 | INSERM U705CNRS UMR 7157 | 0 | 33% | 0.4% | 1 |
7 | NEUROPHARMACOL NEUROSCI MC 136 | 0 | 33% | 0.4% | 1 |
8 | NEUROPHARMACOL NEUROSCI MC136 | 0 | 33% | 0.4% | 1 |
9 | PHARM MONTPELLIER | 0 | 15% | 0.8% | 2 |
10 | NEUROPHYSIOL PHARMACOL | 0 | 13% | 0.8% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000160156 | MITRAGYNINE//MITRAGYNA SPECIOSA//KRATOM |
2 | 0.0000156501 | DEXTROMETHORPHAN//DIMEMORFAN//DEXTRORPHAN |
3 | 0.0000130443 | BLOOD NOW//OBESITY INDEX//BIOX DISCIPLINARY |
4 | 0.0000080887 | ARISTOTELIA CHILENSIS//MURTA UGNI MOLINAE TURCZ//MAQUI |
5 | 0.0000080672 | ASPIDOPHYTINE//ASPIDOSPERMA ALKALOIDS//STRYCHNOS ALKALOIDS |
6 | 0.0000078120 | AYAHUASCA//PSILOCYBIN//PSILOCIN |
7 | 0.0000069225 | HABENULA//LATERAL HABENULA//FASCICULUS RETROFLEXUS |
8 | 0.0000064683 | BEHAVIORAL SENSITIZATION//BEHAV PHARMACOL GRP//CONDITIONED DRUG EFFECTS |
9 | 0.0000063901 | SALVINORIN A//SALVIA DIVINORUM//KAPPA OPIOID RECEPTOR |
10 | 0.0000059805 | NORHARMAN//BETA CARBOLINES//PEGANUM HARMALA |